The University of North Carolina was the top TMIST site for the U.S. LAPS site! UNC Radiology came in #1 for Chapel Hill and #2 for the Hillsborough campus. UNC has accrued over 3,000 subjects for this ongoing clinical screening mammography trial. Congrats to PI Cherie Kuzmiak and the entire team, including Doreen Steed, Markeela Lipscomb, Carly Sronce, Adriana Delgado, Louis Murphy, Hannah Mignosa-Martin, Luigi Troiani, Tracy Carroll, and Desma Jones.
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is the first randomized controlled trial that seeks to identify women in which digital breast tomosynthesis (DBT) may outperform (2D) digital mammography in reducing advanced breast cancer development. The study will create the world’s largest curated dataset of breast cancer screening clinical data, images, and bio-specimens to help researchers tailor future screening to a woman’s individual risk.
TMIST is enrolling 128,000 healthy women ages 45 to 74 at 130 sites throughout North America, South America, Europe, and the Far East.
About TMIST